ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

ATOS Atossa Therapeutics Inc

1,66
0,14 (9,21%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Atossa Therapeutics Inc ATOS NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,14 9,21% 1,66 06:00:06
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,53 1,53 1,70 1,66 1,52
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
29.4.202414:30GLOBEAtossa Therapeutics Announces Expanded Research Agreement..
15.4.202414:30GLOBEAtossa Therapeutics and Quantum Leap Healthcare Announce..
11.4.202414:30GLOBEAtossa to Participate in Noble Capital Markets Emerging..
09.4.202417:59GLOBEAtossa Therapeutics Presents Data from 40mg Cohort of Phase..
01.4.202422:00GLOBEAtossa Therapeutics Announces Year-End 2023 Financial..
19.3.202413:30GLOBEAtossa Therapeutics Provides Five-Year (Z)-Endoxifen..
18.3.202413:30GLOBEAtossa Therapeutics Regains Compliance with Nasdaq Minimum..
12.3.202413:30GLOBEAtossa Therapeutics Appoints Breast Cancer Specialist Tessa..
22.2.202414:30GLOBEAtossa Therapeutics Announces First Patient Dosing of..
07.2.202414:30GLOBEAtossa Therapeutics Announces Full Enrollment..
09.1.202414:30GLOBEAtossa Therapeutics Issues Letter to Shareholders
04.12.202314:30GLOBEAtossa Therapeutics Announces the Appointment of Arezoo..
20.11.202314:30GLOBEAtossa Therapeutics Announces Full Enrollment of Phase 2..
15.11.202323:03EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
15.11.202322:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
15.11.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202315:00EDGAR2Form 8-K - Current report
13.11.202315:00GLOBEAtossa Therapeutics Announces Third Quarter 2023 Financial..
09.11.202315:00EDGAR2Form 8-K - Current report
09.11.202315:00GLOBEAtossa Therapeutics Appoints Financial Executive Jonathan..
30.10.202318:00PRNUSQuantum Leap Healthcare Collaborative Initiates Landmark..
16.10.202322:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
11.10.202314:30PRNUSFast-food consumption by adolescent girls may sow the seeds..
06.10.202322:00EDGAR2Form 8-K - Current report
28.9.202322:28EDGAR2Form 8-K - Current report
18.9.202314:30GLOBEAtossa to Present at Cantor Fitzgerald Global Healthcare..
14.8.202314:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.8.202314:30EDGAR2Form 8-K - Current report
14.8.202314:30GLOBEAtossa Therapeutics Announces Second Quarter 2023 Financial..
08.8.202315:00GLOBEAtossa Therapeutics to Provide Business Update and Report..
20.7.202315:15GLOBEAtossa Therapeutics Receives Approval from Health Canada to..
13.7.202322:20EDGAR2Form 8-K - Current report
13.7.202322:15GLOBEAtossa Therapeutics Regains Compliance with Nasdaq Minimum..
10.7.202315:15GLOBEAtossa Therapeutics Provides Enrollment Update for Ongoing..
06.7.202315:15GLOBEAtossa Therapeutics Announces Sponsored Research Agreement..
28.6.202315:15GLOBEAtossa Therapeutics and Quantum Leap Healthcare Provide..
28.6.202315:01EDGAR2Form 8-K - Current report
27.6.202315:15GLOBEAtossa Therapeutics Announces $10M Stock Repurchase Program
22.6.202322:15GLOBEAtossa Therapeutics Announces Sponsorship of Are You Dense..
21.6.202316:13GLOBEAtossa Therapeutics Granted Additional Patent Protection for..
14.6.202315:15GLOBEAtossa to Participate in Fireside Chat at Healthcare Virtual..
12.6.202315:15GLOBEAtossa Completes Enrollment of Pharmacokinetic Run-In Cohort..
01.6.202315:10GLOBEAtossa Appoints Life Sciences Financial and Operations..
23.5.202313:00GLOBESocietal CDMO Enters Agreement With Atossa Therapeutics to..
15.5.202315:10GLOBEAtossa Therapeutics Announces First Quarter 2023 Financial..
11.5.202315:00PRNUSPhysician-Scientist Dr. Steven Quay Provides Recommendations..
09.5.202315:15GLOBEAtossa to Present a Trial in Progress Poster on its..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock